Published date: 7 June 2018

Last edited date: 7 June 2018

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Approach to market date: 30 June 2018

Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region, Scotland, Wales, Northern Ireland

Value of contract

£0

Procurement reference

CM/EMP/18/344

Published date

7 June 2018

Approach to market date

30 June 2018

Contract start date

1 January 2019

Contract end date

30 June 2019

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

This procurement exercise is intended to let a contract for the supply of a combined atropine and pralidoxime chloride autoinjector.

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2018/2019 £0

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

lynne.nichols@dh.gsi.gov.uk